insights_auto
Why is MEOBF up 10.07%?
Dive Deeperchevron_right
MEOBF:OTCMKTS
Mesoblast Ltd
$1.53
arrow_upward
+10.07%(+0.14) 1D
Oct 9, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MEOBF...
Open
$1.53
High
$1.53
Low
$1.53
Mkt. cap
1.82B
Avg. vol.
387.00
Volume
100.00
52-wk high
$2.59
52-wk low
$1.14
Beta
1.68
Shares outstanding
1.30B
No. of employees
108
Open
$1.53
High
$1.53
Low
$1.53
Mkt. cap
1.82B
Avg. vol.
387.00
Volume
100.00
52-wk high
$2.59
52-wk low
$1.14
Beta
1.68
Shares outstanding
1.30B
No. of employees
108
News stories
From web sources and news partners
ChartMill
·
1 day ago
Friday's session: top gainers and losers in the dow jones index
The Motley Fool
·
5 hours ago
Prediction: This Is What a $5,000 Investment in the Vanguard S&P 500 ETF (VOO) Will Be Worth by 2040
The Washington Post
·
18 hours ago
How major US stock indexes fared Friday 10/9/2026
JournalArta
·
9 hours ago
Nasdaq rises tech shares as software: What to Know
Profile
Mesoblast Limited is an Australian regenerative medicine company. It seeks to provide treatments for inflammatory ailments, cardiovascular disease, and back pain. The company is led by Silviu Itescu, who founded the company in 2004. Wikipedia
About Mesoblast Ltd